Match Document Document Title
7618817 Genetically modified human natural killer cell lines  
The invention provides a natural killer cell, NK-92, modified to express an Fc receptor on the surface of the cell, such as CD16 (FcγRIII-A), or other Fcγ or Fc receptors. The modified NK-92 cell...
7618786 Method for identifying modulators of human orexin-2 receptor  
The present invention provides a new method for identifying modulators of human orexin-2 receptor without utilizing recombinantly produced nucleic acid molecules encoding human orexin receptor...
7618622 Treatment of Parkinson's disease and related disorders using postpartum derived cells  
Cells derived from postpartum tissue such as the umbilical cord and placenta, pharmaceutical compositions comprising such cells, and methods for using such cells and pharmaceutical compositions to...
7618621 Mammalian multipotent neural stem cells and compositions, methods of preparation and methods of administration thereof  
This invention relates to novel mammalian multipotent neural stem cells (MNSCs), compositions thereof, and methods of preparing and administering the cells to diseased, aged or damaged tissue such...
7612167 Human hematopoietic growth regulatory gene product  
The present invention relates to novel human hiwi protein and genes that encode such proteins. The invention is directed toward the isolation and characterization of human hiwi proteins. The...
7611895 Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering  
The invention relates to materials and methods for producing equivalents of tissues of the ocular surface, especially conjunctival tissue equivalents. The method of the invention involves biopsy of...
7611852 Functional cardiomyocytes from human embryonic stem cells  
Human embryonic stem cells form embryoid bodies in culture which contain differentiated human cells. Some of the human cells in embryoid bodies differentiate into cardiomyocytes. Here the...
7604992 Generation of neural stem cells from undifferentiated human embryonic stem cells  
The present invention relates to the generation of neural cells from undifferentiated human embryonic stem cells. In particular it relates to directing the differentiation of human ES cells into...
7604934 Method of screening candidate compounds for susceptibility to biliary excretion by endogenous transport systems  
A method of screening a candidate compound for susceptibility to biliary excretion. The method includes the steps of providing a culture of hepatocytes, the culture having at least one bile...
7601534 Method for multiplying stem cells  
The use of a cellular development inhibitor in a controlled manner in order to maintain an undifferentiated stem cell state, especially one of human stem cells, whereby cell division is permitted.
7595431 Mouse models of human prostate cancer  
The present invention provides an immune deficient mouse having a human prostate xenograft of locally advanced or metastatic prostate cancer and uses thereof.
7595043 Method for processing and using adipose-derived stem cells  
The present invention relates to a device comprising a cell carrier portion containing regenerative cells, e.g., stem and progenitor cells, and a cell carrier containment portion. The device is...
7592176 Method of forming mesenchymal stem cells from embryonic stem cells  
This invention relates to methods of producing a substantially homogenous population of mesenchymal stem cells derived from embryonic stem cells. Also, disclosed is a homogenous population of...
7588937 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells  
A method of differentiating embryonic stem cells into neural and motor cells is disclosed. In one embodiment, the invention comprises culturing a population of cells comprising a majority of cells...
7585676 Retroviral vector  
Provided herein is a retroviral vector comprising, and capable of expressing, a nucleotide of interest (NOI), wherein the NOI encodes an RNA or protein which is harmful to a cell.
7585672 Differentiation of stem cells to endoderm and pancreatic lineage  
Methods are described to increase the proportion of endoderm committed cells and pancreatic lineage cells in a culture of human embryonic stem cells which are undergoing differentiation. The method...
7585670 Automated methods for isolating and using clinically safe adipose derived regenerative cells  
Systems and methods are described that are used to separate cells from a wide variety of tissues. In particular, automated systems and methods are described that separate regenerative cells, e.g.,...
7585618 Treatment of diabetes with milk protein hydrolysate  
A milk protein hydrolysate which is preferably caseinoglycomacropeptide and/or a whey protein in a bioavailable form is used for the manufacture of a composition for the treatment or prevention of...
7582479 Primate embryonic stem cell line  
A purified preparation of primate embryonic stem cells is disclosed. This preparation is characterized by the following cell surface markers: SSEA-1 (−); SSEA-4 (+); TRA-1-60 (+); TRA-1-81 (+);...
7582292 Adipose tissue derived stromal cells for the treatment of neurological disorders  
The present invention relates to a treatment of neural injury and neurodegenerative diseases. Also included in the present invention is the use of adipose tissue derived stromal cells for the...
7575924 Methods and compositions relating to improved lentiviral vectors and their applications  
The present invention provides HIV-derived lentivectors which are safe, highly efficient, and very potent for expressing transgenes for human gene therapy, especially, in human hematopoietic...
7563586 Method of identifying a modulator of a voltage-gated sodium channel using cells expressing Nav1.8 and p11  
The present invention provides a method of identifying a modulator of a voltage gated sodium channel (VGSC), which method comprises bringing into contact a VGSC, a p11 peptide and a test compound...
7556805 Compositions for treatment of melanoma and method of using same  
Melanoma can be treated in a mammalian subject by administering to the subject an immunologically-effective amount of a xenogeneic melanoma-associated differentiation antigen. For example, genetic...
7547551 Transfection of eukaryontic cells with linear polynucleotides by electroporation  
The present invention provides an improved method for gene delivery in eukaryotic cells by electroporation, preferably in human hematopoietic cells, particular dendritic cells. The method of the...
7547546 Progenitor cells from wharton's jelly of human umbilical cord  
Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbours osteogenic progenitor cells and MHC−/−...
7547545 Directed in vitro differentiation of marrow stromal cells into neural cell progenitors  
The invention relates to methods for inducing marrow stromal cells to differentiate into neural cells by way of increasing intracellular levels of cyclic AMP. The invention also encompasses methods...
7544661 Self-assembling peptide amphiphiles and related methods for growth factor delivery  
Amphiphilic peptide compounds comprising one or more epitope sequences for binding interaction with one or more corresponding growth factors, micellar assemblies of such compounds and related...
7544497 Compositions for manipulating the lifespan and stress response of cells and organisms  
Provided herein are methods and compositions for modulating the activity of sirtuin deacetylase protein family members; p53 activity; apoptosis; lifespan and sensitivity to stress of cells and...
7541183 Growth and differentiation of adult muscle stem cells with activators or inhibitors of Wnt signaling  
Compositions and methods for modulating proliferation and/or lineage commitment of stem cells by modulating the Wnt signalling pathways. Modulators of the Wnt signalling pathways and screening...
7534610 3D tissue constructs on the basis of colloidal crystals surface modified by sequential layering  
A cell growth matrix for optimizing 3D organization nutrient delivery, controlling release of differentiation factors and facilitating attachment of cells to a scaffold Colloidal crystals and...
7527974 Embryonic stem cells derived from human somatic cell—rabbit oocyte NT units  
The present invention discloses a process for obtaining somatic cell derived embryonic stem cells (encoded by reprogrammed somatic cell nuclei), ES cell-like cells or other types of embryo-derived...
7527971 Adult stem cell lines  
The present invention is directed to a new cell line, VIT4-G9, which has been deposited as ATCC Accession number PTA-8683.
7527968 Regeneration initiating cells  
Methods and compositions for treating hyperglycemia and pancreatic damage as well as stimulating the repair or regeneration of islet cells are disclosed.
7524640 Inhibiting Smad2/3 signaling promotes neurite outgrowth in dorsal root ganglia  
Regeneration of a lesioned CNS axon of a mature neuron, determined to be subject to regeneration inhibition by Smad2/3 signaling, is promoted by contacting the neuron with an inhibitor of Smad2/3...
7524489 Regeneration and repair of neural tissue using postpartum-derived cells  
Cells derived from postpartum umbilicus and placenta are disclosed. Pharmaceutical compositions, devices and methods for the regeneration or repair of neural tissue using the postpartum-derived...
7521231 Method for preparing engineered tissue  
A method for preparing a human or animal tissue by applying a compressive force to a stack of sheets of living tissue thereby inducing adjacent layers to fuse or adhere to each other. The force is...
7514261 Platelet-derived growth factor protection of cardiac myocardium  
The invention provides methods of treating and preventing loss of tissue vascularization that can occur, for example, upon aging.
7514260 Feeder independent extended culture of embryonic stem cells  
Previous methods for culturing human embryonic stem cells have required either fibroblast feeder cells or a medium which has been exposed to fibroblast feeder cells in order to maintain the stem...
7514259 Isolation and transplantation of retinal stem cells  
The present invention relates to the isolation, in vitro propagation, and transplantation and integration of non-pigmented retinal stem cells derived from the neuroretina of the eye, ex vivo and in...
7514075 Systems and methods for separating and concentrating adipose derived stem cells from tissue  
Systems and methods are described that are used to separate cells from a wide variety of tissues. In particular, automated systems and methods are described that separate regenerative cells, e.g.,...
7510876 Definitive endoderm  
Disclosed herein are cell cultures comprising definitive endoderm cells and methods of producing the same. Also disclosed herein are cell populations comprising substantially purified definitive...
7510874 Stable cell lines expressing HERG1a and HERG1b  
A line of cultured mammalian cells includes HERG1b subunits and optionally HERG1a subunits.
7507581 Inhibition of pancreatic islet aggregation  
A method for improving the health and viability of pancreatic islets and improving the outcome of pancreatic islet transplantations is described. The method includes incubating the islets with an...
7504258 Tissue engineered cellular sheets, methods of making and use thereof  
The disclosure provides methods and composition to build living tissue covered stents and the like. These tissue coated stents provide a barrier against cell migration to the lumen of the vessel....
7504257 Embryonic stem cells and neural progenitor cells derived therefrom  
The present invention provides undifferentiated human embryonic stem cells, methods of cultivation and propagation and production of differentiated cells. In particular it relates to the production...
7501238 Skin substitutes for irritancy testing  
The present invention relates to in vitro cultured skin substitutes, preferably to in vitro cultured skin substitutes that have improved barrier function. In particular, the present invention...
7498169 Extending tissue preservation  
A method of sustaining cells is provided. The method can include providing a non-perfluorocarbon cell storage medium, providing a pre-oxygenated liquid perfluorocarbon in contact with the storage...
7498168 Tooth progenitor cell and method for its production  
The invention relates to the use of a cultured stem cell to produce a tooth progenitor cell.
7494806 Retroviral vectors expressing exogenous gene or exogenous nucleic acid sequences  
Provided are novel vectors and viral vectors capable of expressing exogenous gene or exogenous nucleic acid sequences in a target cell of interest, such as T cells, bone marrow cells, epithelial...
7491534 Methods for altering cell fate to generate T-cells specific for an antigen of interest  
The invention provides methods for altering the expression profile of a cell to convert the cell from one cell type to a desired cell type (e.g., T-cells). These reprogrammed cells may be used in a...